Select Projects

Evaluation of Perfluoroalkyl Substances (PFAS) Risk:  Assessed the toxicological significance of exposure to PFAS in drinking water.  Provided technical oversight for analysis of the literature regarding toxicology, human health effects, and chemical and environmental characteristics of PFAS, and the historical state of knowledge of these topics.

Analysis of Talc Exposure and Ovarian Cancer:  Managed a systematic review of the association between talc and ovarian cancer, as well as a series of risk assessments evaluating the risk of individuals exposed to talc.  Reviewed and analyzed the epidemiology, toxicology, and mechanistic literature regarding evidence of an association.

Risk Assessment of PCB Exposure:  Managed a comprehensive review of the risks of environmental PCB exposure.  Assessed the scientific literature regarding human, animal, and mechanistic evidence, and oversaw the site-specific risk assessment of a potentially exposed population.

Risk Assessment of Hexavalent Chromium:  Provided technical oversight for an assessment evaluating the risks of exposure to hexavalent chromium in soil.  Was responsible for risk calculations for potentially exposed individuals, evaluation of the association between chromium and health effects, and analysis of epidemiology studies.

Risk Assessment of Asbestos Exposure in Electricians:  Managed a series of risk assessments evaluating the risk of mesothelioma and lung cancer in individuals exposed to asbestos-containing electrical products.  Reviewed and analyzed the literature regarding studies of epidemiology, exposure, and alternative causation.  Co-authored a manuscript on the risk of mesothelioma and lung cancer in electricians.

Analysis of Solvent Exposure Association with Non-Hodgkin Lymphoma (NHL):  Managed a review and assessment of the scientific literature addressing associations between solvents, especially benzene, and NHL for a case involving a workers’ compensation claim.  Compiled epidemiology study data for occupational exposures and NHL.

Selected Publications

Yeh, A; Kerper, LE; Prueitt, RL; Beck, BD. 2023. “Considerations in Evaluating Dermal Absorption of Per- and Polyfluoroalkyl Substances (PFAS).” Abstract/Poster #: 4374/P241. Presented at the Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo, Nashville, TN, March 19-23.

Goodman, JE; Kerper, LE; Prueitt, RL; Marsh, CM. 2020. “A critical review of talc and ovarian cancer.” J. Toxicol. Environ. Health B 23 (5) :183-213.

Pizzurro, DM; Seeley, M; Kerper, LE; Beck, BD. 2019. “Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.” Regul. Toxicol. Pharmacol. 106:239-250. doi: 10.1016/j.yrtph.2019.05.008.

Kerper, LE; Lynch, HN; Beck, BD; Pizzurro, DM; Seeley, M.  2019. “Considerations for Grouping Different PFAS Together to Develop Guidance Values.” Presented at the Society of Toxicology (SOT) 58th Annual Meeting, Baltimore, MD, March 10-14

Bailey, LA; Kerper, LE; Rhomberg, LR.  2015. “Naphthalene.” In Hamilton and Hardy’s Industrial Toxicology (Sixth Edition). (Eds.: Harbison, RD; Bourgeois, MM; Johnson, GT), John Wiley & Sons, Inc., Hoboken, NJ., p663-668.

Kerper, LE; Lynch, HN; Zu, K; Tao, G; Utell, MJ; Goodman, JE.  2015. “Systematic review of pleural plaques and lung function.” Inhal. Toxicol. 27 : 15-44.

Goodman, JE; Peterson, MK; Bailey, LA; Kerper, LE; Dodge, DG.  2014. “Electricians’ chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.” Regul. Toxicol. Pharmacol. 68 : 8-15.

Goodman, JE; Kerper, LE; Petito Boyce, C; Prueitt, RL; Rhomberg, LR.  2010. “Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development.” Regul. Toxicol. Pharmacol. 58 : 79-99.

Aschner, M; Kerper, LE.  2000. “Transport of metals in the nervous system.” In Molecular Biology and Toxicology of Metals. (Eds.: Zalups, RK; Koropatnick, DJ), Taylor & Francis Inc., New York, NY., p276-299.